Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
Related Questions
Are there certain patient characteristics that drive you to recommend intralesional 5-FU or MTX for a large SCC on the back?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
What is your experience with itraconazole as a primary or adjunct therapy for individuals with numerous BCCs?
What’s your approach to treating multiple facial BCCs in gorlin syndrome?
How do you approach melanoma patients with a positive sentinel node with extra-nodal extension for definitive surgical management?
How would you manage a large area of multiple, recurrent cutaneous squamous cell carcinomas of the scalp with ulcerations and non-healing areas despite cryotherapy, multiple Mohs procedures, and 5-FU?
In patients with multiple basal cell carcinoma lesions on vismodegib, would you hold vismodegib while delivering radiation therapy to one locally advanced BCC lesion that was not amenable to surgery?
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
What are your favorite strategies in fixing post-surgical depressions from facial flaps?
Have you considered intralesional cempilumab for locally advanced NMSC/KCs prior to surgery?
